文献速递其他结缔组织病

系统性硬化症相关间质性肺病中肠-肺轴的国际化研究

International Investigation of the Gut-Lung Axis in Systemic Sclerosis-Interstitial Lung Disease.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2025-12-08

该多国多中心研究纳入五个大洲七个硬皮病中心的285例系统性硬化症患者,其中62.5%合并间质性肺病,采用鸟枪法宏基因组测序分析肠道菌群,发现合并间质性肺病者具有独特的菌群特征,且特定菌种和功能通路与间质性肺病的影像学范围相关。

要点

  • 在285例系统性硬化症患者中,62.5%合并间质性肺病,平均病程9.8年。
  • 合并间质性肺病者肠道菌群特征与无间质性肺病者不同,表现为候选致病菌种丰度增加。
  • 在103例系统性硬化症相关间质性肺病亚组中,特定菌种和功能通路与间质性肺病影像学范围相关。

核心结论

  • 该多中心研究表明,特定的肠道细菌菌种与系统性硬化症中间质性肺病的存在及其影像学范围相关。
  • 这些菌种和/或其代谢产物可能影响间质性肺病的发病机制,并代表新的治疗靶点。

研究设计与样本

  • 多国多中心研究,纳入来自五个大洲七个硬皮病中心的系统性硬化症伴或不伴间质性肺病患者,采集粪便样本。
  • 采用Illumina NovaSeq 6000进行鸟枪法宏基因组测序,在菌种水平表征微生物组成。
  • 采用胸部高分辨率计算机断层扫描的定量图像分析测量间质性肺病的影像学范围(QILD)。
  • 采用多变量稀疏偏最小二乘分析识别间质性肺病的菌种特征,并确定特定菌种和功能通路是否与QILD相关。

主要发现

  • 共纳入285例参与者,平均病程9.8年,其中62.5%合并间质性肺病。
  • 在所有参与者的多变量分析中,合并间质性肺病者与无间质性肺病者相比具有独特的微生物特征,表现为候选致病菌种丰度增加。
  • 在系统性硬化症相关间质性肺病亚组(n=103)中,特定细菌菌种和功能通路与QILD相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mounting evidence supports an association between the intestinal microbiota and diverse pulmonary pathologies (ie, gut-lung axis). Although intestinal dysbiosis is a feature of systemic sclerosis (SSc), no prior studies have investigated the relationship between intestinal microbiota and SSc-associated interstitial lung disease (ILD) in a multinational cohort. This study aimed to characterize the intestinal microbiota of SSc-ILD and determine whether specific bacterial species and functional pathways are associated with ILD severity. METHODS: Patients with SSc with and without ILD from seven SSc Centers across five continents provided a stool sample. Shotgun metagenomic sequencing was performed using the Illumina NovaSeq 6000 to characterize microbial composition at the species level. Quantitative image analysis of high-resolution computed tomography scans of the chest was used to measure radiologic extent of ILD (QILD). Multivariate sparse partial least squares analyses were employed to identify a species signature of ILD and to determine whether specific species and functional pathways are associated with QILD. RESULTS: Among 285 participants (mean disease duration of 9.8 years), 62.5% had ILD. In a multivariate analysis of all participants, patients with ILD had a unique microbial signature compared to those without ILD characterized by increased abundance of candidate pathobiont species. In a subgroup of participants with SSc-ILD (n = 103), specific bacterial species and functional pathways were associated with QILD. CONCLUSION: This multicenter study demonstrates that distinct intestinal bacterial species are linked to the presence and radiologic extent of ILD in SSc. These species and/or their metabolic products may influence ILD pathogenesis and represent novel treatment targets.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Andréasson K, Young A, Joshi S, et al. International Investigation of the Gut-Lung Axis in Systemic Sclerosis-Interstitial Lung Disease. Arthritis Care Res (Hoboken). 2025. PMID: 40757465. doi:10.1002/acr.25623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。